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Electrospinning of Polycaprolactone Core-shell Nanofibers  
With Anti-Cancer Drug 
Sakib Iqbal, Mujibur Khan, Saheem Absar, Andrew Diamanduros, Samuel Chambers, Maxwell Friel, Quazi Nahida Sultana 
Department of Mechanical Engineering, Georgia Southern University, Statesboro, GA 
 Develop a novel cancer drug delivery system using a 
biocompatible core shell nanostructures for targeted delivery 
and minimize side effects caused by conventional 
chemotherapy method 
 Processing and manufacturing of drug loaded nanofibers and 
determination of structure property relationship. 
 In-vitro drug release and cell viability tests of the drug 
loaded nanofiber in a standard biological media 
MATERIALS AND METHOD 
OBJECTIVES 
 Coaxial electrospinning of biocompatible, biodegradable 
polymer encapsulating anticancer drug 
 Testing of nanofibers in UV-Vis Spectrometer at a controlled 
temperature over a prolonged time period in a biological 
media  
 Different biocompatible polymer with different degradation 
rate  has been used to develop drug loaded nanofibers to get 
variable drug release profile 
 Nanofibers release drug by biodegradation of shell polymer 
of coaxial structure and diffusion from the pores of shell 
 Confocal laser microscopy to represent drug release from the 
fiber mats 
 Cytotoxicity tests were performed with human prostate 
cancer cells in the department of Biology. 
 
EXPERIMENTAL WORK 
 Functionalize drug loaded nanofibers with cancer cell 
targeting agents such as antibody 
 Conjugate nanofibers with pH sensitive polymer to obtain 
capability of delivering drug only at cancer cell environment 
 Develop nanospheres encapsulating drug to obtain better 
permeability into human tissues and blood vessel 
 In-vitro testing of cancer drug delivery device to get the 
cytotoxicity and killing curve 
 Testing of drug loaded nanofibers in a zebra fish containing 
human prostatic cancer cell to show its efficacy 
 
FUTURE WORK 
Electrospinning with coaxial spinneret 
Polycaprolactone 
5-Fluorouracil 
 Polycaprolactone (PCL) solution was prepared by dissolving 14% PCL (avg. mw 80,000) 
into dimethylformamide (DMF) at 110°C 
 5% 5-Fluorouracil (FU) was dissolved into DMF at 60°C 
 1% Rhodamine B and 5% 5-Fluorouracil was dissolved into DMF at 60°C 
 Nanofibers of PCL encapsulating FU was electrospun at 1 ml/hr and 0.2ml/hr flow rate 
respectively under 21KV 
 Nanofibers of PCL encapsulating fluorescent marker Rhodamine B and 5-Fluorouracil was 
electrospun at 0.9ml/hr and 0.2ml/hr flow rate respectively under 21.2KV 
 Nanofiber were collected on a wax-paper on a flat plate collector. Nanofibers were washed 
using deionized water and dried in vacuum chamber for 8hours 
 20x20mm drug loaded nanofibers were put into PBS and their absorbance were recorded at 
265nm using UV-Vis spectrometer to get drug release profile 
 Human prostatic cancer cells were used to determine cytotoxicity of nanofibers 
 
RESULTS 
SEM Images of FU loaded PCL Nanofibers 
SEM Images of PCL Nanofibers After Releasing FU 
EDS Plot Showing Presence of FU in Nanofibers 
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Drug Release Profile of FU Loaded PCL 
Confocal Laser Microscopy of Fibers 
 SEM Images of FU loaded PCL nanofibers show beaded structures which suggests 
drug crystals was encapsulated within it. EDS plot shows negligible amount of drug 
is attached to the surface 
 Drug release profile in a biological media of FU loaded PCL nanofibers exhibit a 
controlled release over a prolonged time period 
 Cell viability test of human prostatic cell confirms the efficacy of FU Loaded PCL 
nanofibers 
 Florescence of Nanofibers in confocal microscopy demonstrate that both FU and 
Rhodamine B is encapsulated within PCL nanofibers 
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Fraction of R+ with 5-FU from nanofibers and Regular R+ media 
Cell Viability Test of Human Prostate Cancer Cells in FU Loaded PCL 
Microscopic Images of Prostate Cancer Cell After Treating With FU Loaded PCL 
Amount of FU loaded PCL nanofibers increasing 
Rhodamine B 
